175 related articles for article (PubMed ID: 8100808)
1. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance.
de Bruïne AP; Wiggers T; Beek C; Volovics A; von Meyenfeldt M; Arends JW; Bosman FT
Int J Cancer; 1993 Jul; 54(5):765-71. PubMed ID: 8100808
[TBL] [Abstract][Full Text] [Related]
2. Biological and clinicopathological significance of endocrine differentiation of gastric adenocarcinoma evaluated by double immunohistochemical labeling for chromogranin A and bromodeoxyuridine.
Hayashi H; Ooi A; Nakanishi I
Jpn J Clin Oncol; 1990 Dec; 20(4):339-48. PubMed ID: 1704442
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin-A expression in gastric and colon cancer tissues.
Park JG; Choe GY; Helman LJ; Gazdar AF; Yang HK; Kim JP; Park SH; Kim YI
Int J Cancer; 1992 May; 51(2):189-94. PubMed ID: 1349007
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of gastric- and intestinal-type endocrine cells in gastric and intestinal mixed intestinal metaplasia of the human stomach.
Otsuka T; Tsukamoto T; Mizoshita T; Inada K; Takenaka Y; Kato S; Yamamura Y; Miki K; Tatematsu M
Pathol Int; 2005 Apr; 55(4):170-9. PubMed ID: 15826243
[TBL] [Abstract][Full Text] [Related]
5. Endocrine differentiation of gastric adenocarcinoma. The prevalence as evaluated by immunoreactive chromogranin A and its biologic significance.
Ooi A; Mai M; Ogino T; Ueda H; Kitamura T; Takahashi Y; Kawahara E; Nakanishi I
Cancer; 1988 Sep; 62(6):1096-104. PubMed ID: 3044573
[TBL] [Abstract][Full Text] [Related]
6. Bcl2 expression and its correlation with neuroendocrine differentiation in colon carcinomas.
Atasoy P; Bozdoğan O; Oztürk S; Ensari A
Tumori; 2004; 90(2):233-8. PubMed ID: 15237588
[TBL] [Abstract][Full Text] [Related]
7. Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy.
Shia J; Tickoo SK; Guillem JG; Qin J; Nissan A; Hoos A; Stojadinovic A; Ruo L; Wong WD; Paty PB; Weiser MR; Minsky BD; Klimstra DS
Am J Surg Pathol; 2002 Jul; 26(7):863-72. PubMed ID: 12131153
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas.
Ferrero S; Buffa R; Pruneri G; Siccardi AG; Pelagi M; Lee AK; Coggi G; Bosari S
Virchows Arch; 1995; 426(6):587-92. PubMed ID: 7655739
[TBL] [Abstract][Full Text] [Related]
9. Endocrine cells in colorectal carcinomas. Immunohistochemical study.
Swatek J; Chibowski D
Pol J Pathol; 2000; 51(3):127-36. PubMed ID: 11247395
[TBL] [Abstract][Full Text] [Related]
10. Chromostatin, a chromogranin A-derived bioactive peptide, is present in human pancreatic insulin (beta) cells.
Cetin Y; Aunis D; Bader MF; Galindo E; Jörns A; Bargsten G; Grube D
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2360-4. PubMed ID: 8096340
[TBL] [Abstract][Full Text] [Related]
11. The incidence of chromogranin A defined endocrine cells decreases with tumour progression in gastric adenocarcinoma.
Ikeda Y; Mori M; Haraguchi Y; Sasaki O; Sugimachi K
Surg Oncol; 1995; 4(5):255-60. PubMed ID: 8850027
[TBL] [Abstract][Full Text] [Related]
12. Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.
Ohike N; Jürgensen A; Pipeleers-Marichal M; Klöppel G
Virchows Arch; 2003 Mar; 442(3):258-65. PubMed ID: 12647216
[TBL] [Abstract][Full Text] [Related]
13. Distribution and coexistence of chromogranin A-, serotonin- and pancreastatin-like immunoreactivity in endocrine-like cells of the human anal canal.
Hörsch D; Weihe E; Müller S; Hancke E
Cell Tissue Res; 1992 Apr; 268(1):109-16. PubMed ID: 1499046
[TBL] [Abstract][Full Text] [Related]
14. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
Drucker DJ; Asa SL; Silverberg J; Brubaker PL
Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin type 2A receptor immunoreactivity in human pancreatic adenocarcinomas.
Pilichowska M; Kimura N; Schindler M; Kobari M
Endocr Pathol; 2001; 12(2):147-55. PubMed ID: 11579680
[TBL] [Abstract][Full Text] [Related]
16. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
[TBL] [Abstract][Full Text] [Related]
17. Endocrine cells in extrahepatic bile duct carcinoma.
Yamamoto M; Takahashi I; Iwamoto T; Mandai K; Tahara E
J Cancer Res Clin Oncol; 1984; 108(3):331-5. PubMed ID: 6150939
[TBL] [Abstract][Full Text] [Related]
18. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker.
Deftos LJ
Endocr Rev; 1991 May; 12(2):181-7. PubMed ID: 2070778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
